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It has been 88 years since the summer day in 1910 when Boston
surgeon Ernest Amory Codman first proposed that hospitals
should publish their mortality rates (1). He reasoned that both
physicians and the public needed to know the outcomes of
medical and surgical care. His ideas were immediately unpop-
ular in the professional community. Concerns were expressed
about differences in the patient case mix, about the effect that
public data release would have on physicians’ willingness to
tackle difficult cases and about migration of patients in re-
sponse to data publication. In recent years many of these
controversies were rekindled by a number of local or statewide
public data releases (2,3). Proponents of such programs say
that physicians need comparative data on outcomes to manage
and improve clinical care. Some proponents say the public has
a right to know the outcomes of clinical care when they choose
the person or institution to provide their medical or surgical
care. Opponents raise concerns about the validity of methods
to adjust for differences in patient case mix, the statistical
instability of low rates of adverse outcomes and the chilling
effect that these data will have on physician decision making.
The only fundamental changes in nearly a century of debate
over this issue are the development of multivariate statistics
and that these data release programs are now a mandated
reality in many areas of the United States.
Perhaps no data release program has undergone more
intense scrutiny than the New York State Cardiac Surgery
Reporting System. This program has been in place since 1988
and initially focused on the short-term outcomes of coronary
artery bypass graft (CABG) surgery. The program has devel-
oped methods for multivariate adjustment for patient case mix
(4) and has reported hospital and physician outcomes since
1991 (5,6). The program has been criticized for physician
“gaming” of the data reports and for inadequacy of its statis-
tical methods (7). However, an article by Jones et al. (8) shows
similarity of results of the multivariate methods used by the
New York State Program and those used in other locations.
Further, validation studies conducted by the New York State
Program showed that gaming the data collection system was
not a likely cause of the differences in risk-adjusted mortality
rates (9). In 1994 the New York State Program reported a
substantial reduction in the perioperative mortality associated
with CABG surgery and attributed this, at least in part, to the
effects of the program (10).
Since then two published articles have used indirect evi-
dence to claim that the improved outcomes of CABG surgery
seen in New York were a result of the migration of sicker
patients to surrounding states or a result of a temporal trend
toward improved outcomes in the United States. Data on
consecutive cases of CABG surgery seen at the Cleveland
Clinic between 1989 and 1993 were examined by Omoigui et al.
(11). Based on 485 patients residing in New York but receiving
CABG surgery at Cleveland Clinic, the authors concluded that
New York patients were more likely than other patients to
have had prior cardiac surgery, to be New York Heart Asso-
ciation functional class III or class IV and have experienced
higher mortality rates. The authors concluded that public
dissemination of outcome data may have been associated with
increased referral of high-risk patients from New York. Exam-
ination of hospital discharge data from Massachusetts were
used by Ghali et al. (12) to evaluate cardiac surgical mortality
at 12 hospitals. These mortality rates improved from 4.7% in
1990 to 3.5% in 1992 and 3.3% in 1994. The authors concluded
that since improvement occurred in Massachusetts, which had
no statewide outcome reporting program, the improvement
reported in New York may have been largely a consequence of
a regional decline in cardiac surgery mortality.
In this issue of the Journal of the American College of
Cardiology, Peterson et al. (13) present an analysis of the
CABG outcomes in New York State. These findings are based
on the national Medicare claims data. They studied claims and
clinical outcomes on over 700,000 CABG procedures to assess
both migration from New York State and average annual
improvement in CABG surgery during the period 1987 to 1992.
The results do not support either migration or temporal
change as the cause of the apparent improvement in CABG
mortality in New York State. Peterson et al. found that the
overall migration from New York State actually decreased
during that period. Further, the comparison with data from
other states showed that New York State had the lowest
CABG mortality in the United States and was the most
improved of the low mortality states during 1987 to 1992.
Why did Peterson et al. reach a different conclusion than
did Omoigui et al. and Ghali et al.? Omoigui et al. showed that,
compared to patients from other areas and to historical
controls, there was an increased severity of CABG patients
referred to the Cleveland Clinic from New York during 1988 to
1992. This was almost certainly true but it may have been
largely a local effect. Omoigui et al. believed this was evidence
of a general migration of CABG patients from New York: it
was not. More comprehensive data presented by Peterson et al.
actually show a decline in migration from New York during
this time period. Ghali et al. showed improvement in CABG
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mortality in Massachusetts between 1990 and 1994. Peterson et
al. also showed improvement in CABG mortality rates in
Massachusetts at approximately the United States average and
improvement in New York at a substantially higher rate. In
both of these instances strong inference required a broader
view. Neither the Cleveland Clinic data nor the Massachusetts
hospital discharge data afforded such a view. Both Omoigui et
al. and Ghali et al. were likely correct in a local sense.
However, the inference based on these local observations was
limited by the scope of their data. The broad scope of the
Medicare claims allowed stronger inference on large-scale
effects than did the local or statewide databases.
The analyses of Peterson et al. are based on Medicare
claims data. Should we believe the Medicare claims data? The
advantages of analyses using the Medicare claims are substan-
tial in that they are the only comprehensive national database
with which to examine the outcomes of CABG surgery among
elderly patients. The claims data track mortality very accu-
rately and also contain highly accurate data on patient age, sex
and place of residence. While some information on comorbid-
ity and acuity may be obtained from the claims data, it is not as
accurate as the primary data collected in research databases or
as prospective data being collected as part of quality improve-
ment efforts (14). For the purpose of studying migration from
New York State however, the Medicare database is ideal. For
the purpose of comparing mortality rates there is a legitimate
concern that these differences in observed mortality are, at
least in part, a consequence of confounding by patient or
disease characteristics. The risk adjustment model of Peterson
et al. included patient, age, sex, race, the presence of acute
myocardial infarction and the Charlson comorbidity index.
Variables such as the results of cardiac catheterization are not
available in the Medicare claims database. When comparing
physicians’ individual practices or the results of individual
hospitals, more clinical detail would allow greater certainty
that the observed outcomes are not distorted by differences in
patient case mix. When large population groups are being
compared, and after accounting for demographic variables,
acuity and comorbidity, residual confounding by patient case
mix is a smaller concern but it cannot be entirely eliminated as
a cause of the observed differences in CABG mortality rates
(15).
How should we react to these differences in adjusted
mortality rates and rates of improvement? Peterson et al.
observed more than twofold differences in CABG mortality by
state and very large differences in the degree of decline in
mortality rates. These differences are invisible from “ground
level.” No hospital or individual practitioner could observe
these differences from their experience. The New York State
initiative demonstrates that clinical care can be substantially
improved. The demonstration of Peterson et al. of wide
variability in CABG mortality rates shows that there is sub-
stantial opportunity for improvement. Clinicians must ask why
do these mortality rates differ and explore internal and exter-
nal collaborative efforts to improve. It is no longer acceptable
to blame the patients. Different systems of care produce
different results. The challenge is to understand the lessons
that these different outcomes have to teach.
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